Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | GLS | O94925 | 1/20 | 0.47 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6043356 | 0.81 | HSD17B10 (0.61) | HSD17B10LMNASMN1; SMN2PKMHPGD | |
| SCHEMBL3281437 | 0.78 | HSD17B10 (1.00) | HSD17B10PKMMAPTALDH1A1POLB | |
| SCHEMBL18074272 | 0.77 | CASP3 (0.67) | HSD17B10LMNASMN1; SMN2PKMHPGD | |
| SCHEMBL6789096 | 0.75 | TDP1 (0.55) | HSD17B10SMN1; SMN2PKMMAPTALDH1A1 | |
| SCHEMBL15071827 | 0.75 | MEN1 (0.47) | SMN1; SMN2PKMHPGDNPSR1HTT | |
| SCHEMBL9447444 | 0.74 | PKM (0.61) | HSD17B10LMNASMN1; SMN2PKMHPGD | |
| SCHEMBL7555289 | 0.74 | MEN1 (0.57) | HSD17B10SMN1; SMN2MAPTKMT2AL3MBTL1 | |
| SCHEMBL7556061 | 0.72 | TDP1 (0.60) | HSD17B10SMN1; SMN2MAPTL3MBTL1GLS | |
| SCHEMBL23027807 | 0.72 | LMNA (1.00) | HSD17B10LMNASMN1; SMN2PKMHPGD | |
| Hydrochloric Acid SCHEMBL9461694 | 0.72 | LMNA (0.50) | HSD17B10LMNASMN1; SMN2PKMHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1651604-B1 | N-´2-(2-PYRIDINYL)ETHYL BENZAMIDE COMPOUNDS AND THEIR USE AS FUNGICIDES | BAYER SAS (FR) | 2014-11-12 | — | — | EP | disclosed |
| US-7723364-B2 | N-[2-(2-pyridinyl) ethyl]benzamide compounds and their use as fungicides | BAYER CROPSCIENCE SA (FR) | 2010-05-25 | — | — | US | disclosed |
| US-20060246102-A1 | N-'2-(2-pyridinyl) ethylbenzamide compounds and their use as fungicides | BAYER SAS (FR) | 2006-11-02 | — | — | US | disclosed |
| EP-1651604-A2 | N-¬2-(2-PYRIDINYL)ETHYL|BENZAMIDE COMPOUNDS AND THEIR USE AS FUNGICIDES | Bayer CropScience S.A. (FR) | 2006-05-03 | — | — | EP | disclosed |
| WO-2005014545-A2 | N-′2-(2-PYRIDINYL) ETHYLBENZAMIDE COMPOUNDS AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE S.A. (FR) | 2005-02-17 | — | — | WO | disclosed |
| EP-1500651-A1 | N-[2-(2-Pyridinyl)ethyl]benzamide compounds and their use as fungicides | Bayer CropScience S.A. (FR) | 2005-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060246102-A1 | N-'2-(2-pyridinyl) ethylbenzamide compounds and their use as fungicides | CYP1A2, CYP4B1, CYP1B1 | HSD17B10 1768/4885LMNA 1980/4885SMN1; SMN2 1751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.